Astena Holdings Co.,Ltd. (JP:8095)
:8095
Want to see JP:8095 full AI Analyst Report?
8095 Stock Chart & Stats
¥483.00
-¥7.00(-1.48%)
At close: 4:00 PM EST
¥483.00
-¥7.00(-1.48%)
Day’s Range― - ―
52-Week Range¥456.00 - ¥540.00
Previous CloseN/A
Volume111.30K
Average Volume (3M)270.46K
Market Cap
¥20.17B
Enterprise Value¥32.96B
Total Cash (Recent Filing)¥10.19B
Total Debt (Recent Filing)¥22.65B
Price to Earnings (P/E)8.8
Beta0.71
Next Earnings
Jul 13, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.73%
Share Statistics
EPS (TTM)54.24
Shares Outstanding41,182,423
10 Day Avg. Volume280,330
30 Day Avg. Volume270,463
Financial Highlights & Ratios
PEG Ratio-0.05
Price to Book (P/B)0.70
Price to Sales (P/S)0.30
P/FCF Ratio37.67
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Improving Gross Margin And Return To ProfitabilityA sustained lift in gross margin to about 35% and a return to positive earnings in 2025 indicate stronger pricing or cost control in core distribution. Higher, more durable margins improve cash generation potential and resilience versus lower-margin peers across economic cycles.
Consistent Positive Revenue TrendSteady, modest revenue growth demonstrates ongoing demand from pharmacies and drugstores and supports scale advantages in procurement and distribution. Predictable top-line expansion underpins longer-term planning and incremental margin improvement opportunities.
Essential Distribution Business With Stable Customer BaseA business centered on pharmaceutical distribution to pharmacies and drugstores benefits from recurring demand, entrenched supplier and customer relationships, and logistical know-how. These structural attributes can sustain revenue and limit competitive churn over time.
Bears Say
Volatile And Weak Free Cash FlowIrregular free cash flow and thin cash conversion versus earnings constrain reinvestment, debt reduction, and dividend sustainability. Persistent working-capital swings and uneven OCF raise execution risk and reduce financial flexibility over the medium term.
Rising Debt And Reduced Balance-sheet FlexibilityAn increase in debt in 2025 amid earnings volatility tightens covenants and limits strategic optionality. Higher leverage elevates refinancing and interest risks, making the company more vulnerable to cyclical shocks and constraining capital allocation priorities over years.
Earnings Volatility And Prior Sizable LossLarge swings in net income, including a substantial 2024 loss, signal execution and margin volatility. This unpredictability complicates forecasting, raises the likelihood of future profit interruptions, and may hinder sustained investments and stakeholder confidence.
Astena Holdings Co.,Ltd. News
8095 FAQ
What was Astena Holdings Co.,Ltd.’s price range in the past 12 months?
Astena Holdings Co.,Ltd. lowest stock price was ¥456.00 and its highest was ¥540.00 in the past 12 months.
What is Astena Holdings Co.,Ltd.’s market cap?
Astena Holdings Co.,Ltd.’s market cap is ¥20.17B.
When is Astena Holdings Co.,Ltd.’s upcoming earnings report date?
Astena Holdings Co.,Ltd.’s upcoming earnings report date is Jul 13, 2026 which is in 33 days.
How were Astena Holdings Co.,Ltd.’s earnings last quarter?
Astena Holdings Co.,Ltd. released its earnings results on Apr 13, 2026. The company reported ¥14.52 earnings per share for the quarter, beating the consensus estimate of N/A by ¥14.52.
Is Astena Holdings Co.,Ltd. overvalued?
According to Wall Street analysts Astena Holdings Co.,Ltd.’s price is currently Overvalued.
Does Astena Holdings Co.,Ltd. pay dividends?
Astena Holdings Co.,Ltd. pays a Semiannually dividend of ¥8.93 which represents an annual dividend yield of 3.73%. See more information on Astena Holdings Co.,Ltd. dividends here
What is Astena Holdings Co.,Ltd.’s EPS estimate?
Astena Holdings Co.,Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Astena Holdings Co.,Ltd. have?
Astena Holdings Co.,Ltd. has 41,182,423 shares outstanding.
What happened to Astena Holdings Co.,Ltd.’s price movement after its last earnings report?
Astena Holdings Co.,Ltd. reported an EPS of ¥14.52 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.833%.
Which hedge fund is a major shareholder of Astena Holdings Co.,Ltd.?
Currently, no hedge funds are holding shares in JP:8095
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Astena Holdings Co.,Ltd.
Astena Holdings Co., Ltd., a Japanese company founded in 1914 and based in Chuo, is engaged in the development and distribution of a wide array of healthcare and chemical products. Its Fine Chemical division specializes in manufacturing and selling active pharmaceutical ingredients (APIs) and vital medical supplies used in treatments for fever reduction, pain relief, inflammation management, and blood vessel constriction. The Medical division focuses on biotechnology-related activities, providing support services for drug development and distributing essential medical equipment. The Health & Beauty Care, and Food segment is responsible for marketing non-prescription medications, raw materials for food and functional food products, and cosmetic ingredients. This division also manages direct-to-consumer sales through online and mail-order platforms, alongside offering contract manufacturing services for cosmetic items. Additionally, Astena Holdings' Industrial Chemicals division produces and supplies specialized chemicals for surface treatment and other industrial applications, serving sectors such as printed circuit boards, electronic devices, general plating processes, and semiconductors. The company, initially known as Iwaki & Co., Ltd., officially adopted the name Astena Holdings Co., Ltd. in June 2021.
Technical Analysis
Pharmarise Holdings Corp.
―
Ohki Health Care Holdings, Inc.
―
Medical System Network Co., Ltd.
―
Tsubota Laboratory Incorporated
―
Chordia Therapeutics Inc.
―
Options Prices
Currently, No data available
---